RESULTS	A significant improvement of FMD ( 6.4 + / -4.4 % from 4.8 + / -3.0 % ; p < 0.05 ) with concomitant reduction of plasma concentrations of sICAM-1 ( 231 + / -75 pg/ml from 339 + / -157 pg/ml ; p < 0.05 ) and sVCAM-1 ( 1134 + / -508 pg/ml from 1386 + / -602 pg/ml ; p < 0.05 ) were observed only in levosimendan treated patients .\